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Abstract
Identifying disease genes from a vast amount of genetic data is one of the most challenging
tasks in the post-genomic era. Also, complex diseases present highly heterogeneous geno-
type, which difficult biological marker identification. Machine learning methods are widely
used to identify these markers, but their performance is highly dependent upon the size and
quality of available data. In this study, we demonstrated that machine learning classifiers
trained on gene functional similarities, using Gene Ontology (GO), can improve the identifi-
cation of genes involved in complex diseases. For this purpose, we developed a supervised
machine learning methodology to predict complex disease genes. The proposed pipeline
was assessed using Autism Spectrum Disorder (ASD) candidate genes. A quantitative mea-
sure of gene functional similarities was obtained by employing different semantic similarity
measures. To infer the hidden functional similarities between ASD genes, various types of
machine learning classifiers were built on quantitative semantic similarity matrices of ASD
and non-ASD genes. The classifiers trained and tested on ASD and non-ASD gene func-
tional similarities outperformed previously reported ASD classifiers. For example, a Random
Forest (RF) classifier achieved an AUC of 0. 80 for predicting new ASD genes, which was
higher than the reported classifier (0.73). Additionally, this classifier was able to predict 73
novel ASD candidate genes that were enriched for core ASD phenotypes, such as autism
and obsessive-compulsive behavior. In addition, predicted genes were also enriched for
ASD co-occurring conditions, including Attention Deficit Hyperactivity Disorder (ADHD). We
also developed a KNIME workflow with the proposed methodology which allows users to
configure and execute it without requiring machine learning and programming skills.
Machine learning is an effective and reliable technique to decipher ASD mechanism by iden-
tifying novel disease genes, but this study further demonstrated that their performance can
be improved by incorporating a quantitative measure of gene functional similarities. Source
code and the workflow of the proposed methodology are available at https://github.com/
Muh-Asif/ASD-genes-prediction.
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Introduction
Complex diseases with a strong genetic influence, such as Autism Spectrum Disorder (ASD),
often have multiple etiologies with the involvement of possibly hundreds of different genes.
Recent advances in genetic technologies have led to more efficient acquisition of genetic data.
For example, the many large-scale genetic studies for ASD have identified hundreds of candi-
date disease [1,2]. However, given the vast amount of data generated by these large-scale stud-
ies, identifying true disease genes has become a daunting task. For example, a genetic etiology
is identified for only 20 to 25% of ASD cases [3], thus demanding more efforts to unravel ASD
causing genes.
Random walk with restart (RWR) algorithm has been widely used for disease gene predic-
tion [4,5]. Recently machine learning methods have become a powerful computational tech-
nique in analyzing genomic datasets [6]. Supervised machine learning methods trace hidden
relationships among disease-causing genes in existing datasets, such as gene co-expression
profiles, functional similarities, or protein-protein interactions networks; and then uses this
information to discriminate disease genes from non-disease genes [7–9]. Machine learning
methods are helping biologists to define genomic features that could have a role in disease
mechanism. Krishnan et al. [10] reported a weighted Support Vector Machine (SVM) classifier
to predict the probability of association of each brain gene with ASD. The weighted SVM was
trained on a specialized gene network that integrates gene expression, protein-protein interac-
tions, and regulatory-sequence information of brain genes. However, classifier evaluation was
limited to a subset of genes that were high confidence ASD genes. Such held out restricted
evaluation of classifiers may overestimate classifier performance. Moreover, there are limita-
tions for protein-protein interactions and co-expression networks. For example, it is difficult
to map weak interactions on interactions networks, thus, limiting the scope of disease gene
prediction. To overcome the shortcomings of network-based annotations, studies have used
Gene Ontology (GO) (http://www.geneontology.org/) [11], which is a highly efficient resource
for predicting disease-causing genes [12].
Functionally similar genes tend to contribute to similar phenotype. For instance, etio-
logically relevant genes disrupted by genetic variants in ASD patients tend to aggregate in
specific biological processes [13], indicating that disease genes may belong to the same hier-
archical path of GO and will have higher functional similarities. Therefore, functional simi-
larity of genes, measured using GO, can also be used to predict potential ASD candidate
genes.
In this study, we hypothesized that machine learning methods trained and tested only on
GO-based gene functional similarities can be used to predict disease-associated genes with
improved performance over state of the art methods [10]. We validated the performance of
classifiers using the same assessment approach as done by Krishnan et al., namely held-out
restricted cross-validation. In addition, classifiers were also validated by stratified five-fold
cross-validation. Different machine learning methods were applied to a functional similarity
matrix of known ASD and non-mental genes. Classifiers trained and tested only on gene
functional similarities performed better than the state of the art method. This shows that GO
functional similarity is a relevant resource to predict ASD genes. Thus, machine learning
methods trained and tested on gene semantic similarities can effectively narrow down the
genetic complexity of ASD. Additionally, a classifier built on high confidence ASD genes
obtained improved performance, and hence could be used for ASD gene prediction. We also
presented a fully automated and customizable KNIME workflow of the proposed methodol-
ogy, which can be used to identify any other type of disease genes.
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Methods
Overview of the proposed methodology
In this study, we developed a machine learning based methodology for the identification of
disease genes. Fig 1 shows the generic pipeline of the proposed methodology. For any given set
of disease-relevant and non-relevant genes, a functional similarity matrix is constructed (step
1). Functional similarities between genes can be determined using gene expression profiles,
protein-protein interactions networks, or GO. Different machine learning algorithms are
trained and tested on functional similarity matrices (step 2 and 3). To avoid biased estimates, a
reasonably balanced ratio of disease and non-disease genes is required. An easy to use and
automated workflow of the proposed methodology, using the KNIME machine learning
framework, is also provided for the users with minimal programming or machine learning
skills.
Machine learning methods
For this study, we used different machine learning classification methods, such as Naive Bayes
(NB) [14], linear and radial SVM [15], and a decision tree based method, Random Forest (RF)
[16]. Supervised machine learning methods have been widely used to predict disease genes. A
comparison of classification based methods can be found in Le et al. [17].
RF, linear and radial SVM, and NB were trained on functional similarities of disease and
non-disease genes. RF is an ensemble learning method and builds a forest of decision trees.
Each tree in forest is a separate weak model that is trained with a randomly selected subset of
data and each node of the tree is split by random selection of features from training data. This
randomness permits RF to create many uncorrelated weak models, which are then combined
to generate a robust and stable model. In the case of classification, the final class attributions
from RF are the result of consensus voting from all weak models. RF was applied using the fol-
lowing parameters: number of trees (ntree) = 500; number of variables randomly selected at
each split (mtry) equal to the square root of the total number of features (Breiman et al.’s rec-
ommended value), random sampling with replacement; and equal class weights assumed for
both positive and negative classes. We used the RF implementation from the randomForest R
package (version 4.6–12) [18].
Fig 1. Main components of the proposed methodology to predict disease genes. Functional similarities are
computed for a given set of genes. Different machine learning methods are applied to functional similarity matrices to
define rules that discriminate disease genes from non-disease genes. Two evaluation approaches, namely stratified and
held-out restricted stratified five-fold cross-validation are used.
https://doi.org/10.1371/journal.pone.0208626.g001
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The SVM is a heuristic optimization method that tends to discover coordinates of observa-
tions, called support vectors, to determine a decision hyperplane that best segregates both clas-
ses (positive and negative) with maximum margins in an n-dimensional space, where n is the
number of features used to model. SVM can be used as a linear or non-linear method by defin-
ing kernel function. In non-linear SVM the dot products of linear SVM are replaced with ker-
nel function that allows the algorithm to map data in higher dimensional feature space. In this
study, we used linear SVM and radial kernel-based SVM to predict disease genes. Linear and
radial SVM was applied using e1071 (version 1.6.8) R package [19]. Equal class weights were
defined for both positive and negative classes. 1 and 0.001 values were used for cost and epsilon
parameters respectively. For radial-SVM gamma was set to 0.02.
NB is a simple probabilistic classifier based on the Bayes’ theorem with the assumption of
strong (naive) independence between every pair of predictors. This simplest Bayesian classifier
can be trained efficiently and performs well in practice, even when the assumption of features
independence is not valid. It was trained as a conditional probability model, where conditional
probability distribution of each observation is estimated using Bayes’ theorem and then uses it
for the prediction of class labels for test set instances. NB was applied using e1071 R package.
NB was used without Laplace smoothing.
Evaluation of the classifiers
All classifiers were evaluated using two different assessment approaches, namely stratified five-
fold cross-validation and held-out restricted stratified five-fold cross-validation, adapted from
the Krishnan et al. study. Stratified five-fold cross-validation consists of following steps:
1. Split the dataset into five equal folds with class probabilities similar to the original dataset
2. Train classifier on four randomly selected folds (training set)
3. Test the trained classifier using the remaining fold (test set).
4. Repeat the process five times and each time a different fold is used as a test set.
In held-out restricted stratified five-fold cross-validation, the classifier is tested using a sub-
set of test set (step 3), named as held-out.
Similar to Krishnan et al.’s method, the Area Under receiver-operator Curve (AUC) evalua-
tion metric was used to estimate and compare the performance of all generated classifiers. To
avoid bias from self-similarity scores, during cross-validation, the semantic similarity squared
matrix was split into five folds. So, genes selected to be as instances in the test set were removed
as features from the test and training set. This avoided the usage of self-similarity values in the
test set. For example, for a given set of five genes: g1 . . .g5, the semantic similarity matrix is of
5x5 dimensions. If g1 . . .g3 are used as instances in the training set then g4 and g5 are in the
test set so they cannot be used as features in the training set. The training set matrix is there-
fore reduced to 3x3 dimensions with the three genes: g1 . . .g3. Therefore, to avoid any bias,
test set instances were excluded from test and training set features list, resulting in a reduced
number of features for both test and training sets.
Class imbalance effect
An undersampling was employed to deal with situations where an imbalance in positive and
negative instances was observed. During classifier design, the majority class (negatives) was
undersampled in each training fold of five-fold cross-validation. For this purpose, the PercPos
method from unbalanced R package was used and perc value was set to 30, resulting in a subset
Identifying disease genes using machine learning and functional similarity
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of 30% positive and 70% negative instances. The five-fold cross-validation of classifiers built
on undersampled datasets was repeated 20 times and the mean AUC value was reported.
Constructing functional similarity matrix
Functional similarities between genes were determined using GO annotations. GO is a struc-
tured and controlled vocabulary of terms to describe gene products. GO is structured as a
Directed Acyclic Graph (DAG) in which terms are represented as nodes and relationships
between different terms are represented as edges. The ease of searching and richness in biolog-
ical information has made GO an imperative resource for studying genes characteristics.
Resnik [20], Wang [21], and Relevance (Rel) [22] semantic similarity measures with Maximum
(Max) combining strategy were used to construct functional similarity matrices for disease
and non-disease genes. Rel and Resnik are Information Content (IC) based measures. Let p(c)
be the probability of usage of GO term c in a given GO corpus. The IC of a term can be defined
as:
ICðcÞ ¼   logðpðcÞÞ ð1Þ
IC-based methods compute a semantic score between two GO terms using the IC of their
Most Informative Common Ancestor (MICA) term. Wang measure uses the hierarchical
structure of the GO to calculate the semantic similarity scores between the given terms.
The Max strategy of combining semantic similarity scores across all GO terms associated
with given genes was used. Let g1 and g2 are two different genes annotated with following list
of GO terms (t11,t12 . . .. . . t1m) and (t21,t22 . . .. . . t2n), respectively. The max combining criteria
compute the maximum semantic similarity score over all possible pairs of terms between the
two term lists as follows:
maxðg1; g2Þ ¼ max1�i�m;1�j�n � ðt1i; t2jÞ ð2Þ
GO terms with electronic evidence code (IEA) were dropped during semantic similarity
score calculation. GO information for both ASD and non-mental genes were obtained from
org.Hs.eg.db R package [23]. Only terms from the biological process aspect were used to assess
functional similarities between the genes. All semantic similarity measures were implemented
using GOSemSim (version 2.0.4) R package [24]. To guarantee that the results are independent
of the measure, we decided not to use our in-house developed DiShIn tool and measure [25],
but we expect to get similar or better performance with more refined measures.
There are more than 40 thousand GO terms representing biological concepts. However,
some genes still lack GO information and result in missing semantic scores. Genes with miss-
ing similarity scores were excluded at the beginning of the analysis. We did not assign 0 values
to missing scores, to avoid confusion because there were with the genes in dataset that really
had a semantic similarity of 0. Therefore, replacing missing scores with 0 can induce bias in
predictions and also could result in a bias estimation of classifier performance. All disease gene
prediction approaches largely depend upon data and each dataset has its own limitations. For
example, protein-protein interaction networks have the limitation of not considering weakly
interacting proteins, as these are difficult to ascertain experimentally. Similarly, the presented
approach is also dependent upon gene semantic similarities scores, which were unavailable for
a few genes. However, in our dataset, semantic scores were missing for only 170 genes (9.5%).
Out of which 96 (14.6% of positive instances [disease genes]) belong to the positive class and
74 (6.5% of negative instances [non-disease genes]) were negatives. This small percentage of
positive instances with missing similarities will not have a significant effect on classifier
performance.
Identifying disease genes using machine learning and functional similarity
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Automated workflow
To make the designed methodology accessible to researchers lacking extensive machine learn-
ing and programming knowledge, we developed an easy to use workflow. The workflow was
developed using the KNIME framework (https://www.knime.com/). KNIME is an open source
framework implementing several machine learning algorithms and data analysis utilities. The
developed automated KNIME workflow incorporates all the above-discussed machine learn-
ing and semantic similarity measures to predict disease genes.
Case study dataset
To implement the proposed methodology, genes with evidence for an involvement in ASD
were obtained from the Simons Foundation Autism Research Initiative (SFARI) gene database
(N = 990) (https://gene.sfari.org/), accessed on March 2018. The SFARI gene database is a cata-
logue of ASD relevant genes that have been reported by previous studies. In the SFARI data-
base, genes are scored into seven different categories with respect to the strength of the
available evidence. Genes with strongest and reproducible evidence are assigned to category 1
and genes with certain reproducibility limitations are placed in category 2. Category 3 and 4
contains genes with evidence from small studies of ASD candidate genes, while genes belong-
ing to category 5 have indirect evidence of association. Category 6 genes are not associated
with ASD. The SFARI gene database also contains syndromic genes that cause genetic patholo-
gies presenting with ASD symptoms. Syndromic genes are placed in a separate syndromic cat-
egory. Genes from category 1, 2, 3 and 4 (N = 588) were selected for the analysis. All genes
classified as syndromic but are not in these categories were excluded. Besides ASD association,
syndromic genes are also associated with diverse phenotypes and may disrupt biological pro-
cesses unrelated to ASD. SFARI genes of category 1 and 2 were designated as High confidence
Disease (HD) genes (N = 82), while genes from 3 and 4 SFARI categories were considered as
Low confidence Disease (LD) genes (N = 506) (Fig 2). Non-mental genes (N = 1189) were
obtained from the Krishnan et al. (10).
Fig 3 shows the methodology used to predict ASD genes. We modelled the task of predict-
ing disease genes using machine learning methods as a binary classification problem, positive
Fig 2. Classifying ASD database genes into HD genes and LD genes using the available evidence strength.
https://doi.org/10.1371/journal.pone.0208626.g002
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class (+1) for disease genes and negative (-1) for non-disease genes. Therefore, all ASD genes,
HD and (HD + LD) composed the positive class, while non-mental genes composed the nega-
tive class. Negative class genes were re-examined for their ASD relevance and 49 of them were
found in ASD gene database. These genes were considered as ASD genes and were assigned to
the positive class.
Experimental setup
RF, NB, linear-SVM, radial-SVM based classifiers were generated on each semantic similarity
matrix (computed using Resnik, Wang, and Rel semantic measures). The classifiers were
divided into two different categories depending upon validation strategy and ASD genes clas-
ses (HD and LD)
First, classifiers were trained and tested on HD and non-mental genes and were evaluated
using stratified five-fold cross-validation. There were less HD ASD genes than non-mental
genes. Therefore, to control class imbalance, the majority class (non-mental genes) was under-
sampled. Secondly, functional similarities of HD + LD and non-mental genes were calculated
to design various classifiers. The performance of these classifiers was assessed using two differ-
ent assessment approaches, namely stratified five-fold cross-validation and held-out restricted
five-fold cross-validation.
Fig 3. Graphical representation of the methodology to predict ASD genes. A. ASD genes with different level of
evidence and non-mental genes were used to implement the proposed methodology. B. Three different semantic
similarity measures were used to calculate functional similarities for HD + non-mental genes and for HD + LD + non-
mental genes. C. Four different machine learning methods were used to analyze the computed gene functional
similarities. Machine learning classifiers were tested using stratified and held-out restricted stratified five-fold cross-
validation. Like the Krishnan et al. method in the held-out restricted validation, only HD + non-mental genes were
chosen for testing the classifier. In stratified five-fold cross-validation, classifiers were evaluated using all genes in the
test set.
https://doi.org/10.1371/journal.pone.0208626.g003
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Predicting new ASD genes using the semantic similarity based classifier
Copy Number Variants (CNVs) are common genetic risk factors for many diseases, including
ASD. Specially, de novo CNVs play an important role in ASD pathogenesis and occur at higher
rates in patients than in their siblings or controls [26]. Mostly, de novo CNVs (present in
patients but not in their parents) frequently disrupt many genes, posing challenges for the
identification of the disease among the many disrupted genes.
ASD candidate gene predictions were made to further estimate the predictability of the built
classifier. For this purpose, genes disrupted by rare de novo CNVs (N = 80) in ASD patients
were obtained from Sander et al. [27]. We used our generated classifier to predict ASD genes
from genes spanned by rare de novo CNVs in subjects that were diagnosed with ASD. Genes
overlapping with training set and lacking GO annotations were excluded from analysis.
Results
In this study, we evaluated the performance of machine learning methods in predicting the
ASD candidate genes. For this purpose, functional similarities of ASD genes along with non-
mental genes were calculated by applying semantic similarity measures. Table 1 shows the per-
formance of different machine learning classifiers constructed over functional similarities
scores, determined by using three different semantic similarity measures.
Resnik, Wang, and Rel measures were used to calculate functional similarities for HD ASD
and non-mental genes. Four different machine learning methods (RF, NB, linear-SVM, and
radial-SVM) were trained on each semantic similarity matrix, resulting in total of twelve differ-
ent classifiers for HD genes. Out of these classifiers, RF-based classifiers trained and tested on
all semantic similarity matrices outperformed the other classifiers (Table 1). RF classifier
trained on Resnik semantic scores obtained best results than the other RF classifiers, although
the differences in AUC values were minor, indicating the independence of the methodology to
the semantic measure. Linear and radial SVM failed to classify HD ASD genes. The stratified
five-fold cross-validation approach was used to evaluate all the classifiers of HD and non-men-
tal genes.
Table 1. The performance of classifiers trained and tested over different semantic similarities matrices and validated using stratified and held-out restricted strati-
fied validation. The performance of the Krishnan et al.’s method in terms of AUC value: unweighted HD genes based classifier = 0.73, weighted HD + LD classifier = 0.74,
weighted HD + LD classifier and evaluated with HD genes = 0.80–0.89.
Semantic similarity measure Classifiers HD genes HD + LD genes
Fivefold validation Fivefold validation Held-out fivefold validation
Resnik RF 0.80 0.75 0.82
NB 0.73 0.66 0.70
Linear-SVM 0.28 0.59 0.62
Radial-SVM 0.49 0.59 0.59
Wang RF 0.75 0.73 0.81
NB 0.71 0.67 0.76
Linear-SVM 0.26 0.59 0.59
Radial-SVM 0.54 0.59 0.59
Rel RF 0.77 0.74 0.82
NB 0.70 0.64 0.75
Linear-SVM 0.28 0.61 0.62
Radial-SVM 0.51 0.62 0.57
HD: High confidence Disease genes; LD: Low confidence Disease genes.
https://doi.org/10.1371/journal.pone.0208626.t001
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Classifiers were also built using functional similarities of HD + LD and non-mental genes
and were evaluated by stratified five-fold cross-validation. The performance of classifiers for
each semantic similarity matrix of HD + LD genes and non-mental genes was lower than the
HD genes based classifiers, except for linear, and radial SVM (Table 1). RF classifier trained
and tested on Resnik semantic scores of HD + LD genes and non-mental genes achieved
higher AUC value than the other classifiers of HD + LD genes. Similarly, for HD genes, the
performance of RF classifiers trained and tested separately on HD+LD semantic similarities
matrices, computed using Wang, Resnik, and Rel measures, was comparable (Table 1).
A held-out restricted validation approach was adapted from Krishnan et al. to assess the
performance of the proposed classification approach. For this purpose, classifiers were built
using functional similarities of HD + LD genes and non-mental genes. However, during strati-
fied five-fold cross-validation, evaluation was done using only HD ASD and non-mental
genes. For each semantic similarity matrix, held-out restricted RF classifier outperformed HD
and HD+LD classifiers (evaluated using stratified five-fold cross-validation). In parallel with
previously built classifiers (HD and HD+LD), the performance of held-out restricted classifiers
for all semantic similarity measures was comparable (Table 1). Despite the improved perfor-
mance than HD and HD+LD classifiers, held-out restricted linear and radial SVM failed to
classify ASD genes (Table 1). NB classifiers that were evaluated only on HD genes also
obtained better performance over other classifiers, evaluated without any restriction. However,
improved performance of NB classifiers was only observed for Wang and Rel semantic scores
(Table 1).
The reported semantic similar matrices, Resnik, Rel and Wang were calculated using the
Max combining criteria. Semantic similar matrices were also calculated by the Boot Mean
Average (BMA) combining criteria. However, classifiers constructed using genes semantic
scores with the BMA combining criteria showed lower performance than classifiers built on
semantic scores of Max combining criteria (S1 Table).
We also have developed a KNIME workflow of the designed methodology. The instantia-
tion of the proposed methodology is described in Fig 4. The workflow comprised four different
Fig 4. The architecture of the automated workflow for predicting disease genes. Functional similarity layer is the
instantiation of methodology step 1, while the classifier layer implements the steps 2 and 3 of proposed methodology
(Fig 1).
https://doi.org/10.1371/journal.pone.0208626.g004
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layers, 1) input layer, 2) functional similarity layer, 3) classifier layer, and 4) output layer. The
input layer takes a list of disease and non-disease genes as input. For this list, the functional
similarity matrix is calculated in the second layer by selecting a semantic similarity measure
(one out of Wang, Resnik, and Rel measures). The classifier layer implements RF, NB, linear-
SVM, and radial-SVM machine learning methods with stratified five-fold cross-validation.
Lastly, the fourth layer measures the classifier performance by estimating AUC for the gener-
ated classifiers. The designed workflow serves as a tool to predict disease genes. It can be
extended according to the specific objective such as adding another class of disease genes. This
workflow also incorporates R nodes to calculate functional similarity between genes, thus
allowing programming experts to add any new method by modifying the corresponding R
node. Moreover, the model generated using automated workflow can be saved on the local
computer and can also be easily invoked to make predictions for new datasets.
To predict novel ASD candidate genes from genes disrupted by de novo CNVs in patients,
we used our best classifier, namely the RF classifier trained and tested on Resnik semantic sim-
ilarity matrix, calculated using HD and non-mental genes. This RF-Resnik classifier was also
evaluated by tuning its parameters, such as number of trees. RF classifier showed the highest
performance when the number of trees was set to 500 (S2 Table). The classifier predicted 73
ASD genes out of 554 genes that were disrupted by denovo CNVs in ASD patients. The Enrichr
[28] tool was employed to find enriched biological pathways and Human Phenotype Ontology
(HPO) terms for predicted genes. Only the histone modifications pathway was marginally sig-
nificantly enriched for predicted genes (adjusted p = 0.065 at α< 0.05). However, 99 HPO
terms were found significantly enriched for 73 predicted genes (Table 2 and S3 Table). The top
2 most significantly enriched HPO terms were Vesicoureteral reflux and Autism.
Discussion
Complex diseases exhibit a multifactorial etiology, rendering the identification of biological
markers challenging. For example, ASD is a complex neurodevelopmental disorder for which
diagnosis relies solely on behavior assessment because efficient biological markers are absent
so far. Herein, we reported a machine learning based methodology to predict ASD genes.
Table 2. Top 16 enriched HPO terms for predicted ASD genes.
HPO term ID HPO term Adjusted p-value
HP:0000076 Vesicoureteral reflux 5.21303E-05
HP:0000717 Autism 0.000232356
HP:0000582 Upslanted palpebral fissure 0.000232356
HP:0002999 Patellar dislocation 0.000232356
HP:0001636 Tetralogy of Fallot 0.000650645
HP:0001537 Umbilical hernia 0.000798236
HP:0007018 Attention deficit hyperactivity disorder 0.000798236
HP:0002120 Cerebral cortical atrophy 0.001075744
HP:0000113 Polycystic kidney dysplasia 0.00210752
HP:0000670 Carious teeth 0.002213532
HP:0010669 Cheekbone underdevelopment 0.002678489
HP:0005293 Venous insufficiency 0.003171264
HP:0003072 Hypercalcemia 0.003377945
HP:0000232 Everted lower lip vermilion 0.003377945
HP:0002624 Venous abnormality 0.005095958
HP:0000722 Obsessive-compulsive behavior 0.005670617
https://doi.org/10.1371/journal.pone.0208626.t002
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Overall, independently from the gene-weighting criteria our RF classifier trained only on
gene semantic similarity scores (generated using HD ASD and non-mental genes) obtained
higher performance than the Krishnan et al HD ASD genes based classifier, which used pro-
tein-protein interaction, gene expression, and gene regulatory information of genes to predict
ASD candidate genes [10]. Krishnan et al. was selected as state of the art method because to the
best of our knowledge was the most recent application of machine learning techniques to iden-
tify ASD genes. The study included extensive validation of their methodology and reported
real applications in solving a biological problem. We also used the same genes, both ASD and
non-ASD genes. Another reason for choosing Krishnan et al. was to compare results from
held-out and stratified fivefold cross-validations. The objective was to study which approach is
more suitable.
The HD ASD genes based classifier also outperformed the RF classifiers using the semantic
similarities of all known ASD (HD + LD) genes. The reduced performance of the classifier
trained on HD + LD genes could be explained due to the large number of genes that have
weak evidence of involvement in ASD, including, for example, 339 genes from SFARI category
4. Further studies are required to verify the associations of these genes with ASD. Moreover,
our classifier trained on HD + LD ASD genes but evaluated on only HD ASD genes as held-
out showed better performance than the held-out restricted weighted classifier of Krishnan
et al.. However, evaluating classifier performance using only HD ASD genes may provide
biased estimates. ASD presents a wide spectrum of clinical phenotype. The classifier tested on
only HD ASD genes may lack robustness for genes that are responsible for a milder expression
of ASD or for comorbidities, thus limiting the coverage of the predictive classifier.
The strength of the reported semantic similarity scores is its independence from the fea-
tures (genes) weighting scheme, defined by the ranking of genes according to available evi-
dence. The standard criteria for ranking ASD genes by available reference is not yet
completely defined [29], and, therefore, it is possible that incorporating weighting criteria for
genes could introduce a bias. In the present study, we used semantic similarity scores of genes,
which range from 0 to 1, with semantic similarity scores closer to 1 indicating high functional
similarity between genes. If the gene is not directly involved in ASD then the target gene will
show less similarity with disease-causing genes, hence lowering its contribution in classifica-
tion. For this reason, we did not apply any weighting criteria. This automates the process and
allows increasing performance as GO evolves.
The improved performance of the classifier with semantic similarities further confirmed
the importance of GO annotations in predicting disease genes. GO provides a consistent and
deeper level of biological information than the protein-protein interactions or genes expres-
sion profiles. Functional information from GO structure can overcome the shortcomings of
protein-protein interactions and expression profiles because GO annotations are less depen-
dent on context. Additionally, our study further confirmed that machine learning methods
can be used to predict disease genes and their performance can be improved by adding more
data with different domain information.
One limitation of this approach is the full dependence on the available annotation resources.
Genes lacking GO annotations are filtered in the analysis. But this may improve in future
because the number of GO terms and annotations are continuously increasing with time.
We also provided a downloadable and easy to use workflow of the designed methodology.
The designed workflow permits the user to test more than one machine learning and func-
tional similarity methods. The workflow allows domain-specific experts to replicate the
reported methodology to identify disease-causing genes and use their knowledge to further
improve the predictions by tuning the parameters according to their need. The developed
workflow includes all necessary tools for disease gene prediction and provides an opportunity
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for researchers to analyze their own private data without uploading it to external websites, thus
preventing any privacy issues.
Enrichment analysis revealed the enrichment of ASD predicted genes in histone modifica-
tion pathway. This was consistent with previously published studies, reporting histone genes
involvement in ASD [30]. Only one pathway was significantly enriched for ASD predicted
genes. This might be because of a small number of input ASD genes. Prediction with larger
number of genes might produce more statistically significant pathways.
ASD core symptoms are defined by deficits in social interaction and communication, and
repetitive behavior. However, these core symptoms manifest with a wide range of phenotype,
indicating ASD phenotypic heterogeneity. Functional enrichment analysis of ASD genes, pre-
dicted by the RF classifier also showed a wide range of phenotypes. ASD predicted genes were
enriched in Autism and obsessive-compulsive behavior phenotypes, further confirming the fea-
sibility of the classifier in predicting new ASD genes. In addition, five genes were also associ-
ated with the attention deficit hyperactivity disorder HPO term. Attention deficit hyperactivity
is one of most the common ASD comorbidity. A large percentage of ASD children also
develop attention deficit hyperactivity disorder symptoms [31].
Although Random Forest (RF) performed better than other methods, its performance was
comparable with Naive Bayes (NB) algorithm. Therefore, we do not expect that RF will achieve
the best performance for other complex disease genes as well. The Support Vector Machines
(SVMs), both linear and nonlinear failed to make reasonable predictions, probably, they are
sensitive to number of features and number of records. Also, SVMs perform preprocessing of
data, which may not be feasible for this dataset.
In this study, we reported that gene functional similarities, assessed using GO annotations
can be used to identify new ASD genes. The classifier trained and tested using HD ASD genes out-
performed all others and previously reported classifiers. The objective of this work was not to find
the best semantic similarity measure for calculating functional similarities of genes. However, the
performance of the classifier can be further improved by including more refined semantic similar-
ity methods. Additionally, text mining techniques may also be employed to find the functionality
of genes in literature that are lacking semantic scores [32]. Moreover, to attain reliable ASD genes
predictions, future studies should be focused on combining protein-protein interactions with
semantic similarity scores. Additionally, integration of information such as gene expression and
pathways data with semantic scores can further improve the power of prediction.
In summary, we validated our hypothesis and have shown that the performance of available
state of the art methods for complex disease gene prediction can be improved by using only
GO annotations. One novel aspect of presented manuscript was the comparison of stratified
and held-out restricted cross-validation. The results indicated that classifiers built on GO
annotations did not require held-out restricted classifiers. Approximately equivalent perfor-
mance to ASD held-out restricted classifiers can be achieved by training machine learning
methods, validated using five-fold cross-validation, on semantic similarity scores of only high
confidence ASD disease genes. This work demonstrated that machine learning methods are a
feasible approach to dissect the genetic heterogeneity of complex diseases such as ASD and to
find novel disease genes. The results of this study can also further assist in designing genetic
screening and lab experiments on ASD genetic risk factors.
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